InvestorsObserver
×
News Home

Should You Sell CureVac BV (CVAC) Stock Monday Morning?

Monday, November 29, 2021 08:37 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell CureVac BV (CVAC) Stock Monday Morning?

CureVac BV (CVAC) has risen Monday morning, with the stock adding 2.26% in pre-market trading to 45.18. CVAC's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 35% of stocks. CureVac BV has risen 10.26% over the past month, closing at $42.10 on November 1. During this period of time, the stock fell as low as $35.33 and as high as $46.55. CVAC has an average analyst recommendation of Sell. The company has an average price target of $53.00.

Overall Score - 25
CVAC has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on CVAC!
CureVac BV has a Long-Term Technical rank of 24. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 76% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, CVAC ranks better than 51% of stocks.

Important Dates for Investors in CVAC:

-We do not have a set earnings date for CureVac BV at this time. -We do not have a set dividend date for CureVac BV at this time. Click Here To Get The Full Report on CureVac BV (CVAC)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App